What is the current medical soft capsules market size?

The medical soft capsules market size is approximately USD 1.2 billion as of 2023.

What are the key drivers of the medical soft capsules market?

Key drivers include rising healthcare costs and growing demand for convenient medication formats.

What challenges does the medical soft capsules market face?

Challenges include stringent regulatory requirements and high production costs.

Which regions are leading the medical soft capsules market?

North America and Europe are leading the market due to high demand and established healthcare infrastructure.

Who are the top companies in the medical soft capsules market?

Top companies include Capsugel, Catalent, and Aenova, which offer high-quality products and services.

What future opportunities exist in the medical soft capsules market?

Future opportunities include emerging markets and innovative technologies, such as 3D printing and nanotechnology.

How is technology impacting the medical soft capsules market?

Technology is improving manufacturing efficiency, product quality, and patient outcomes, driving future outlook.

What is the regulatory landscape for the medical soft capsules market?

The regulatory landscape is complex, with strict guidelines from FDA and EMA, requiring compliance and certification.

What is the expected future outlook for the medical soft capsules market?

The future outlook is positive, with increasing demand and growth opportunities in emerging markets and technologies.

medical soft capsules Market Metrics & Forecast Analysis 2033

medical soft capsules by Application (Hospital, Clinic, Medical Institutions, Others), by Types (Gelatin Type, Non-Animal Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

medical soft capsules Market Overview

The medical soft capsules market refers to the global industry involved in the production and distribution of soft capsules used for pharmaceutical and healthcare applications. The medical soft capsules market size is expected to reach $8.5 billion by 2026, driven by a growing demand for efficient and effective drug delivery systems. As the growth outlook for the industry remains positive, the market forecast suggests a compound annual growth rate (CAGR) of 7.5% during the forecast period. The industry expansion is expected to be driven by advancements in technology, changing regulations, and shifting consumer behavior, ultimately shaping the scope of the medical soft capsules market, which encompasses various types of capsules, including gelatin, vegetarian, and hybrid capsules, used in applications such as pharmaceuticals, nutraceuticals, and cosmetics.

Loading chart…

The medical soft capsules market is driven by key forces such as technology shifts, regulations, and consumer behavior. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific. The growth forecast for the industry is positive, with a CAGR of 7.5% during the forecast period. The market size is expected to reach $13.4 billion by 2033, driven by the increasing demand for soft capsules in the pharmaceutical and nutraceutical industries. Overall, the medical soft capsules market is expected to experience significant growth and expansion during the forecast period, driven by advancements in technology, changing regulations, and shifting consumer behavior.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Aenova; Catalent; Boehringer Ingelheim; Nature’s Bounty; Patheon (Thermo Fisher Scientific); Procaps; AstraZeneca; Aland; Vertex; Novartis; EuroCaps; Strides Pharma Science; Captek; Soft Gel Technologies; NextPharma (from Lonza); Roche; Amway; Sirio Pharma Co.,Ltd; Weihai Baihe Biology Technological Co.,Ltd; Douglas; Shineway Pharma; Tsinghua Unigroup; Donghai Pharm; Yi Chao; Yuwang Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The medical soft capsules market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these factors is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing demand for oral drug delivery systems that offer improved bioavailability and patient compliance is driving the growth of the medical soft capsules market size. This demand is further fueled by advancements in technology that enable the development of capsules with tailored release profiles.

The growth forecast for the medical soft capsules market is also influenced by the expanding geriatric population and the rising prevalence of chronic diseases, which require long-term medication and, consequently, boost the demand for soft capsules.

Restraints2 items

Stringent regulatory requirements and the high cost associated with the development and approval of new drugs are significant restraints in the medical soft capsules market. These factors can limit the market size by reducing the number of new product launches.

The availability of alternative drug delivery systems, such as tablets and injectables, also poses a challenge to the growth of the medical soft capsules market, as they offer competitive advantages in terms of cost and convenience.

Opportunities2 items

The increasing focus on personalized medicine and targeted therapies presents opportunities for the medical soft capsules market, as these capsules can be engineered to deliver drugs in a manner that is tailored to the individual patient's needs.

The emerging markets in Asia and Latin America, characterized by a large and growing population, increasing healthcare expenditure, and improving healthcare infrastructure, offer significant opportunities for the expansion of the medical soft capsules market size.

Challenges2 items

The supply chain disruptions and raw material shortages can impact the production of medical soft capsules, leading to fluctuations in their price and availability. This challenge necessitates the development of resilient supply chains and strategic sourcing practices.

The competition from generic drugs and the pressure to reduce healthcare costs also pose significant challenges to the growth of the medical soft capsules market, requiring manufacturers to develop cost-effective solutions without compromising on quality.

Market Segmentation

Loading chart…

The application segment of the medical soft capsules market refers to the various uses of soft capsules in the medical industry, including prescription drugs, over-the-counter drugs, and nutraceuticals. This segment is crucial in determining the overall size of the medical soft capsules market, as different applications have varying demands for soft capsules. Understanding the medical soft capsules segmentation by application is essential for market players to identify opportunities and challenges in the industry.

The types segment of the medical soft capsules market includes subtypes such as gelatin soft capsules and non-gelatin soft capsules. Each subtype has its own set of characteristics, advantages, and disadvantages, which affect their adoption in the medical industry. Analyzing the market taxonomy of medical soft capsules by type helps in understanding the preferences of manufacturers and consumers, ultimately contributing to the overall market size. The medical soft capsules segmentation by type is vital for industry stakeholders to develop strategies and make informed decisions.

medical soft capsules Segmentation Breakdown8 items

Application

Hospital

Clinic

Medical Institutions

Others

Types

Gelatin Type

Non-Animal Type

Regional Insights

Loading chart…

The medical soft capsules market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and the fastest-growing region, driven by increasing adoption of soft capsules in the pharmaceutical industry. Key drivers for Asia Pacific include investments in healthcare infrastructure, a growing ecosystem maturity of pharmaceutical companies, and a large demographics of patients requiring medication.

In North America, key drivers include policies supporting the development of generic drugs, a mature infrastructure for pharmaceutical manufacturing, and a high adoption rate of soft capsules among patients. Europe is driven by a strong ecosystem of pharmaceutical companies, investments in research and development, and a growing demographics of elderly patients. Latin America and Middle East & Africa are driven by increasing adoption of soft capsules, investments in healthcare infrastructure, and a growing demographics of patients.

The regional forecast indicates that Asia Pacific will continue to dominate the market, with a regional forecast growth rate of 10% per annum. North America and Europe will experience steady growth, while Latin America and Middle East & Africa will experience rapid growth, driven by increasing demand for medical soft capsules.

Competitive Landscape

The medical soft capsules market is moderately consolidated, with a mix of global players and local/regional companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The medical soft capsules competitive landscape is driven by these key factors, with companies focusing on building strong relationships with distributors and investing in research and development to stay ahead. Global players are expanding their presence in emerging markets, while local companies are leveraging their understanding of regional preferences to gain market share.

Companies in the medical soft capsules market are adopting various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new markets. They are also focusing on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies are prioritizing their strategic focus areas, such as regional expansion, innovation pipeline, and local manufacturing.

GSK: regional expansion

Aenova: innovation pipeline

Catalent: premium pricing

Boehringer Ingelheim: OEM tie-ups

Nature’s Bounty: local manufacturing

Patheon: vertical integration

Key medical soft capsules Companies26 items

GSK

Aenova

Catalent

Boehringer Ingelheim

Nature’s Bounty

Patheon (Thermo Fisher Scientific)

Procaps

AstraZeneca

Aland

Vertex

Novartis

EuroCaps

Strides Pharma Science

Captek

Soft Gel Technologies

NextPharma (from Lonza)

Roche

Amway

Sirio Pharma Co.,Ltd

Weihai Baihe Biology Technological Co.,Ltd

Douglas

Shineway Pharma

Tsinghua Unigroup

Donghai Pharm

Yi Chao

Yuwang Group

Market Ecosystem

The medical soft capsules ecosystem encompasses a complex network of stakeholders, from upstream suppliers to downstream end-users, with value creation and capture occurring at various stages. The ecosystem can be broadly segmented into three stages: upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end-users. Understanding the interplay between these stakeholders is crucial for conducting a thorough value chain analysis of the medical soft capsules ecosystem.

Raw material suppliers — provide gelatin or non-gelatin materials

OEMs / manufacturers — produce soft capsules

Technology providers — develop encapsulation machinery

System integrators / EPCs — integrate production lines

Distributors / channel partners — supply to pharmacies or hospitals

Regulators/standards bodies — enforce quality and safety standards

End users / buyers — pharmacies, hospitals, or patients

The flow of value in the medical soft capsules ecosystem is influenced by various control points, including regulatory bodies that enforce quality and safety standards, and manufacturers that dictate production capacities. Dependency risks arise from input constraints, such as the availability of raw materials, and standards and approvals required for market entry. Switching costs and partnerships can also impact the ecosystem, with companies forming alliances to ensure a stable supply of materials or to access new markets. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market demands affecting the production and distribution of medical soft capsules.

Recent Industry Insights

The medical soft capsules industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on expanding product portfolios and enhancing manufacturing capabilities. For instance, companies have collaborated to develop innovative soft capsule formulations with improved bioavailability and targeted release mechanisms. Additionally, there have been notable mergers and acquisitions, such as the acquisition of smaller capsule manufacturers by larger pharmaceutical companies, aiming to strengthen their position in the market.

Furthermore, the industry has seen the launch of new products and technologies, including vegetarian and halal-certified soft capsules, catering to the growing demand for dietary supplements and nutraceuticals. Regulatory changes, such as updated guidelines for good manufacturing practices, have also influenced the medical soft capsules industry trends. Moreover, shifting consumer preferences towards sustainable and eco-friendly packaging have prompted companies to invest in research and development of environmentally responsible soft capsule solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the medical soft capsules market outlook. The market attractiveness is high due to increasing demand for oral medications and pharmaceutical innovations. Competitive intensity is moderate, with key players focusing on research and development to gain a competitive edge. The long-term outlook is positive, driven by growing healthcare needs and an expanding geriatric population.

The innovation landscape is evolving, with advancements in material science and manufacturing technologies. However, the demand–supply balance may be affected by regulatory changes and raw material shortages. Key risk factors include quality control issues and supply chain disruptions. Overall, the medical soft capsules market outlook is promising, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. medical soft capsules Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global medical soft capsules Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global medical soft capsules Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global medical soft capsules Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global medical soft capsules Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global medical soft capsules Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global medical soft capsules Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global medical soft capsules Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global medical soft capsules Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global medical soft capsules Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global medical soft capsules Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global medical soft capsules Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global medical soft capsules Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global medical soft capsules Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global medical soft capsules Market Competition by Key Manufacturers

9.1. Global medical soft capsules Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global medical soft capsules: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GSK

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Aenova

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Catalent

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Boehringer Ingelheim

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nature’s Bounty

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Patheon (Thermo Fisher Scientific)

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Procaps

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. AstraZeneca

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Aland

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Vertex

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Novartis

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. EuroCaps

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Strides Pharma Science

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Captek

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Soft Gel Technologies

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. NextPharma (from Lonza)

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Roche

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Amway

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Sirio Pharma Co.,Ltd

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Weihai Baihe Biology Technological Co.,Ltd

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Douglas

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Shineway Pharma

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Tsinghua Unigroup

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Donghai Pharm

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Yi Chao

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Yuwang Group

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global medical soft capsules Market

Figure 4: Global medical soft capsules Market: Drivers

Figure 5: Global medical soft capsules Market: Challenges

Figure 6: Global medical soft capsules Market: Trends

Figure 7: Global medical soft capsules Market: Opportunity

Figure 8: Global medical soft capsules Market: Restraint

Figure 9: Global medical soft capsules Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global medical soft capsules Market Value (USD Million) By Region

Figure 19: Global medical soft capsules Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global medical soft capsules Market Value (USD Million) By Region

Figure 27: Global medical soft capsules Market Share (%) By: Regions (2032)

Figure 28: Global medical soft capsules Market Volume (K) By Region

Figure 29: Global medical soft capsules Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global medical soft capsules Market Value (USD Million) By Region

Figure 37: Global medical soft capsules Market Share (%) By: Regions (2032)

Figure 38: Global medical soft capsules Market Volume (K) By Region

Figure 39: Global medical soft capsules Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

147 items

Table 1: Market Segmentation Analysis

Table 2: Global medical soft capsules Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global medical soft capsules Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global medical soft capsules Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global medical soft capsules Market Value (USD Million) By Region

Table 14: Global medical soft capsules Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global medical soft capsules Market Volume (K) By Region

Table 31: Global medical soft capsules Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global medical soft capsules Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global medical soft capsules Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global medical soft capsules Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GSK Basic Information And Sales Area

Table 52: GSK. Products Portfolio

Table 53: Aenova Basic Information And Sales Area

Table 54: Aenova. Products Portfolio

Table 55: Catalent Basic Information And Sales Area

Table 56: Catalent. Products Portfolio

Table 57: Boehringer Ingelheim Basic Information And Sales Area

Table 58: Boehringer Ingelheim. Products Portfolio

Table 59: Nature’s Bounty Basic Information And Sales Area

Table 60: Nature’s Bounty. Products Portfolio

Table 61: Patheon (Thermo Fisher Scientific) Basic Information And Sales Area

Table 62: Patheon (Thermo Fisher Scientific). Products Portfolio

Table 63: Procaps Basic Information And Sales Area

Table 64: Procaps. Products Portfolio

Table 65: AstraZeneca Basic Information And Sales Area

Table 66: AstraZeneca. Products Portfolio

Table 67: Aland Basic Information And Sales Area

Table 68: Aland. Products Portfolio

Table 69: Vertex Basic Information And Sales Area

Table 70: Vertex. Products Portfolio

Table 71: Novartis Basic Information And Sales Area

Table 72: Novartis. Products Portfolio

Table 73: EuroCaps Basic Information And Sales Area

Table 74: EuroCaps. Products Portfolio

Table 75: Strides Pharma Science Basic Information And Sales Area

Table 76: Strides Pharma Science. Products Portfolio

Table 77: Captek Basic Information And Sales Area

Table 78: Captek. Products Portfolio

Table 79: Soft Gel Technologies Basic Information And Sales Area

Table 80: Soft Gel Technologies. Products Portfolio

Table 81: NextPharma (from Lonza) Basic Information And Sales Area

Table 82: NextPharma (from Lonza). Products Portfolio

Table 83: Roche Basic Information And Sales Area

Table 84: Roche. Products Portfolio

Table 85: Amway Basic Information And Sales Area

Table 86: Amway. Products Portfolio

Table 87: Sirio Pharma Co.,Ltd Basic Information And Sales Area

Table 88: Sirio Pharma Co.,Ltd. Products Portfolio

Table 89: Weihai Baihe Biology Technological Co.,Ltd Basic Information And Sales Area

Table 90: Weihai Baihe Biology Technological Co.,Ltd. Products Portfolio

Table 91: Douglas Basic Information And Sales Area

Table 92: Douglas. Products Portfolio

Table 93: Shineway Pharma Basic Information And Sales Area

Table 94: Shineway Pharma. Products Portfolio

Table 95: Tsinghua Unigroup Basic Information And Sales Area

Table 96: Tsinghua Unigroup. Products Portfolio

Table 97: Donghai Pharm Basic Information And Sales Area

Table 98: Donghai Pharm. Products Portfolio

Table 99: Yi Chao Basic Information And Sales Area

Table 100: Yi Chao. Products Portfolio

Table 101: Yuwang Group Basic Information And Sales Area

Table 102: Yuwang Group. Products Portfolio

Table 103: Global Market Value (USD Million) (2025-2032) By Application

Table 104: Global Market Share (%) By Application (2032)

Table 105: Global Market Value (USD Million) (2025-2032) By Types

Table 106: Global Market Share (%) By Types (2032)

Table 107: Global Market Volume (K) (2025-2032) By Application

Table 108: Global Market Share (%) By Application (2032)

Table 109: Global Market Volume (K) (2025-2032) By Types

Table 110: Global Market Share (%) By Types (2032)

Table 111: Global medical soft capsules Market Value (USD Million) By Region

Table 112: Global medical soft capsules Market Share (%) By Region (2025-2032)

Table 113: North America Market Value (USD Million) (2025-2032) By Country

Table 114: North America Market Value (USD Million) (2025-2032) By Application

Table 115: North America Market Value (USD Million) (2025-2032) By Types

Table 116: Europe Market Value (USD Million) (2025-2032) By Country

Table 117: Europe Market Value (USD Million) (2025-2032) By Application

Table 118: Europe Market Value (USD Million) (2025-2032) By Types

Table 119: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 120: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 121: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 122: South America Market Value (USD Million) (2025-2032) By Country

Table 123: South America Market Value (USD Million) (2025-2032) By Application

Table 124: South America Market Value (USD Million) (2025-2032) By Types

Table 125: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 126: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 127: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 128: Global medical soft capsules Market Volume (K) By Region

Table 129: Global medical soft capsules Market Share (%) By Region (2025-2032)

Table 130: North America Market Volume (K) (2025-2032) By Country

Table 131: North America Market Volume (K) (2025-2032) By Application

Table 132: North America Market Volume (K) (2025-2032) By Types

Table 133: Europe Market Volume (K) (2025-2032) By Country

Table 134: Europe Market Volume (K) (2025-2032) By Application

Table 135: Europe Market Volume (K) (2025-2032) By Types

Table 136: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 137: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 138: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 139: South America Market Volume (K) (2025-2032) By Country

Table 140: South America Market Volume (K) (2025-2032) By Application

Table 141: South America Market Volume (K) (2025-2032) By Types

Table 142: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 143: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 144: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 145: Research Programs/Design For This Report

Table 146: Key Data Information From Secondary Sources

Table 147: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

medical soft capsules Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Aenova; Catalent; Boehringer Ingelheim; Nature’s Bounty; Patheon (Thermo Fisher Scientific); Procaps; AstraZeneca; Aland; Vertex; Novartis; EuroCaps; Strides Pharma Science; Captek; Soft Gel Technologies; NextPharma (from Lonza); Roche; Amway; Sirio Pharma Co.,Ltd; Weihai Baihe Biology Technological Co.,Ltd; Douglas; Shineway Pharma; Tsinghua Unigroup; Donghai Pharm; Yi Chao; Yuwang Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

medical soft capsules Segmentation Breakdown8 items

Application

Hospital

Clinic

Medical Institutions

Others

Types

Gelatin Type

Non-Animal Type

Regional Insights

Loading chart…

Competitive Landscape

GSK: regional expansion

Aenova: innovation pipeline

Catalent: premium pricing

Boehringer Ingelheim: OEM tie-ups

Nature’s Bounty: local manufacturing

Patheon: vertical integration

Key medical soft capsules Companies26 items

GSK

Aenova

Catalent

Boehringer Ingelheim

Nature’s Bounty

Patheon (Thermo Fisher Scientific)

Procaps

AstraZeneca

Aland

Vertex

Novartis

EuroCaps

Strides Pharma Science

Captek

Soft Gel Technologies

NextPharma (from Lonza)

Roche

Amway

Sirio Pharma Co.,Ltd

Weihai Baihe Biology Technological Co.,Ltd

Douglas

Shineway Pharma

Tsinghua Unigroup

Donghai Pharm

Yi Chao

Yuwang Group

Market Ecosystem

Raw material suppliers — provide gelatin or non-gelatin materials

OEMs / manufacturers — produce soft capsules

Technology providers — develop encapsulation machinery

System integrators / EPCs — integrate production lines

Distributors / channel partners — supply to pharmacies or hospitals

Regulators/standards bodies — enforce quality and safety standards

End users / buyers — pharmacies, hospitals, or patients

Recent Industry Insights

Analyst Overview

Table of Contents